Myanmar is gradually emerging from decades of international isolation. It shares long, porous borders with China and India, the world’s two most populous states. Despite its rich natural resources, Myanmar is one of Asia's poorest countries, and faces serious health challenges. It has the second-highest number of HIV-positive people in Southeast Asia, after Thailand. Myanmar is also among the 22 countries with the highest TB burden, and TB prevalence is nearly three times the global average; there are also high levels of multidrug-resistant TB. With mass distribution of mosquito nets and artemisinin-based combination therapy, malaria rates have plummeted in recent years. However, Myanmar still accounts for more than half of all malaria deaths in its region. Artemisinin resistance in the Greater Mekong sub-region, including in Myanmar, is a serious global threat, particularly if it crosses to neighboring countries and then onward to Africa.

The Global Fund / John Rae

Investments to Date

Component Signed Committed Disbursed

Disbursements by Component


For documents pertaining to a specific grant, please select a grant from the list.